Sign In
Buy LXRX
$1.85
-0.0400 (-2.12%)
At Close: Jun 03, 2026
Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023
04:00pm, Friday, 28'th Apr 2023
THE WOODLANDS, Texas, April 28, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2023 financial results on Tuesday, May 2, 2023 after the markets cl
Should You Buy This Growth Stock Right Now Before It Potentially Doubles?
08:15am, Saturday, 22'nd Apr 2023
Lexicon is awaiting word from regulators about what could be its first product. Previously, regulators rejected its attempts to commercialize a similar program.
THE WOODLANDS Texas, April 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc . (Nasdaq: LXRX), today announced that results from RELIEF-PHN-1, a Phase 2 double-blind, placebo-controlled trial
Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
05:00pm, Tuesday, 28'th Feb 2023
THE WOODLANDS, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter 2022 financial results on Thursday, March 2, 2023 after the market
Nothing Ever Comes Easy For Lexicon, But Maybe Sotagliflozin Will Prevail In Heart Failure
08:00am, Sunday, 25'th Dec 2022
I discuss Lexicon's long and tumultuous history. Sotagliflozin has a PDUFA in May 2023 for a heart failure indication.
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2022 Earnings Call Transcript
09:34pm, Wednesday, 09'th Nov 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Mike Kelly – Investor Relations Lonnel Coats – Chief Executive Office
Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
08:58am, Friday, 04'th Nov 2022
THE WOODLANDS, Texas, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its third quarter 2022 financial results on Wednesday, November 9, 2022, after the ma
5 Penny Stocks To Buy For Under $5
11:23am, Friday, 12'th Aug 2022
Hot penny stocks to watch or buy for under $5? Here's a list of .penny stocks gaining momentum today The post 5 Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q2 2022 Results - Earnings Call Transcript
11:30pm, Tuesday, 02'nd Aug 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Participants Mike Kelly - Investor Relations Lonnel Coats - Chief Executive Officer Jeff
Lexicon Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 2, 2022
08:00am, Friday, 29'th Jul 2022
THE WOODLANDS, Texas, July 29, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2022 financial results on Tuesday, August 2, 2022 after the market
Lexicon: Beaten Down Stock, High Risk-Reward Situation Ahead
11:00am, Tuesday, 31'st May 2022
Lexicon has not been lucky with the FDA. However, there are reasons, discussed below, which make me see a special situation here.
7 Biotech Stocks With Key Catalysts for May
06:35am, Wednesday, 11'th May 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. The post 7 Biotech Stocks With Key Catalysts for May appeared first on Investo
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2022 Results - Earnings Call Transcript
10:53am, Thursday, 05'th May 2022
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX ) Q1 2022 Results Conference Call May 5, 2022 8:00 AM ET Company Participants Charles Schultz - Investor Relations Lonnel Coats - President and Chief Executi
Lexicon Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 5, 2022
08:00am, Friday, 29'th Apr 2022
THE WOODLANDS, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2022 financial results on Thursday, May 5, 2022 before the markets
New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)
12:01pm, Monday, 21'st Mar 2022 GlobeNewswire Inc.
Late-breaking clinical trial presentation by Deepak L. Bhatt, M.D., M.P.H., will describe new analysis of rates of CV death, myocardial infarction and stroke in the SCORED trial Late-breaking clinical
